WellTheory, a virtual care platform for autoimmune disease, has announced a new women’s health program focused on addressing hormonal conditions including PCOS, endometriosis, postpartum, hypothyroidism, perimenopause, and menopause. The program aims to support women dealing with the interconnected challenges of autoimmune disease and hormone imbalances. The initiative comes in response to significant gender disparities in autoimmune disease, with women making up 80…
You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your Inner Circle account to access this content. If you aren’t a member yet and would like to find out more about our Inner Circle program or sign up, click here.
Wisp, a women’s telehealth provider in the U.S., has announced the launch of a new weight care vertical specifically designed to address weight management challenges related to hormonal conditions. The WELL Health Technologies subsidiary, which serves over 1.2 million patients, is expanding its services to include GLP-1 medications and other weight management solutions. The new program specifically targets women struggling with hormonal…
Venture Life Group has announced the acquisition of Health & Her (H&H) for an upfront cash consideration of £7.5 million, with additional payments of up to £2.5 million tied to performance and retention milestones. The acquisition strengthens Venture Life’s position in the rapidly growing hormone health market. Founded in 2018 and headquartered in Cardiff (UK), H&H has established itself as a leading…
Persperity Health, a Caltech spin-out, has secured $1 million in pre-seed funding to develop sweat-sensing technology for non-invasive hormone monitoring. The round was led by Freeflow Ventures, with participation from Caltech, Wilson Hill Ventures, Heritage Group, and ATMA Capital. The company’s technology, exclusively licensed from Caltech and developed by Dr. Wei Gao and Dr. Cui Ye, enables real-time hormone monitoring through sweat…
Bayer has announced a partnership with deep-tech startup Impli to advance the development of what could become the first real-time hormone monitoring device. The collaboration aims to make fertility treatment more accessible, safer, and more successful while exploring broader applications of hormone monitoring technology. The partnership follows Impli’s win at a Bayer-sponsored innovation challenge during the HLTH Europe conference earlier this year.…
In what could mark a significant shift in fertility treatment, Celmatix has announced the nomination of its first lead compound in its oral Follicle Stimulating Hormone receptor (FSHR) agonist drug development program. The breakthrough, announced during the American Society for Reproductive Medicine (ASRM) annual meeting in Denver, could potentially transform fertility treatments by replacing traditional hormone injections with oral medications. The development…
Perelel, a women’s health company offering stage-specific hormonal and reproductive support, has acquired LOOM, an educational community platform for reproductive health, sexual wellness, and parenting education. This acquisition combines Perelel’s medically-backed approach with LOOM’s community-driven educational platform. Founded in 2020 by Victoria Thain Gioia and Alex Taylor, alongside Medical Co-Founder Dr. Banafsheh Bayati, Perelel offers targeted nutrition for different stages of a…
